Key points are not available for this paper at this time.
INSTI use was associated with increased risk of new-onset diabetes mellitus/hyperglycemia in the 6 months following ART initiation.
Share your take
Add a clinician perspective alongside expert commentary.
O’Halloran et al. (Tue,) studied this question.